Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05159388
Title A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pieris Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | BEL | AUS

Facility Status City State Zip Country Details
Carolina Bio Oncology TERMINATED Huntersville North Carolina 28078 United States Details
NEXT Oncology TERMINATED San Antonio Texas 78229 United States Details
Cabrini Oncology Research RECRUITING Malvern Victoria Australia Details
Chris O'Brian Lifehouse RECRUITING Camperdown Australia Details
The Queen Elizabeth Hospital RECRUITING Woodville South Australia Details
Institute Jules Bordet RECRUITING Brussels Belgium Details
Universitair Ziekenhuis RECRUITING Edegem Belgium Details
U.Z. Gent Medical Oncology RECRUITING Gent Belgium Details
Hospital Vall d'Hebron RECRUITING Barcelona Spain Details
START RECRUITING Madrid 28050 Spain Details
Hospital Universitario Gregorio RECRUITING Madrid Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field